Asker Healthcare Group's subsidiary, OneMed, has acquired Kirstine Hardam to enhance its offerings in critical care sectors in Denmark, leveraging the latter's expertise in ostomy, wound care, nutrition, and incontinence management.
Target Information
Kirstine Hardam is a specialized firm operating in Denmark, focusing on the sale of branded products for ostomy care, wound care, nutrition, and incontinence management. With a dedicated workforce of 20 employees, the company generated revenues of approximately 200 million kronor in 2024. Its expertise and product portfolio enhance support for patients in post-operative care through high-quality medical supplies.
The acquisition by OneMed, a subsidiary of Asker Healthcare Group, signifies a strategic alignment that will leverage Kirstine Hardam's established reputation and strong market presence in Denmark. This partnership is poised to enhance OneMed's offerings in critical care areas where patient support is vital.
Access Full Deal Insights
You’re viewing a public preview of this deal. To unlock full access to ca. 50,000 other deals in our database and join ca. 400 M&A professionals who are using it daily, sign up for Dealert.
Industry Overview in Denmark
The healthcare industry in Denmark is characterized by a comprehensive welfare system that ensures high access to medical services for all citizens. As one of the most innovative healt
Similar Deals
Philip Morris International → Fertin Pharma
2023
OneMed
invested in
Kirstine Hardam
in 2024
in a Other deal
Disclosed details
Revenue: $20M